Anti-cancer drug composition containing amentoflavone

A kind of technology of biflavonoids and anticancer drugs, applied in the field of biomedicine

Inactive Publication Date: 2015-09-02
TAISHAN MEDICAL UNIV
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, Chinese herbal medicine has not become the first choice of anticancer drugs at home and abroad,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-cancer drug composition containing amentoflavone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: the anticancer pharmaceutical composition containing the biflavone

[0036] The composition and parts by weight of the anticancer pharmaceutical composition crude drug containing biflavone are as follows:

[0037] 11 parts by weight of the biflavone of Suicha chinensis, 28 parts by weight of picroside, 10 parts by weight of syringin, and 40 parts by weight of swerticoside.

Embodiment 2

[0038] Embodiment 2: the anticancer drug composition that contains the biflavone of spike fir

[0039] The composition and parts by weight of the anticancer pharmaceutical composition crude drug containing biflavone are as follows:

[0040] 33 parts by weight of biflavonoids of Suicha spicacoside, 16 parts by weight of picroside, 25 parts by weight of syringin, and 30 parts by weight of swertiroside.

Embodiment 3

[0041] Embodiment 3: the anticancer drug composition containing the biflavone

[0042] The composition and parts by weight of the anticancer pharmaceutical composition crude drug containing biflavone are as follows:

[0043] 22 parts by weight of the biflavone of Suohuaxiu glycoside, 20 parts by weight of picroside, 17 parts by weight of syringin, and 35 parts by weight of swertiroside.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anti-cancer drug composition containing amentoflavone. The drug composition adopts the amentoflavone, swertiamarin, syringopicroside and false Chinese swertia herb as bulk drugs which are matched to prepare various dosage forms according to the conventional preparation technology. The drug composition provided by the invention has significance on preparing anti-cancer drug, especially anti-hepatoma drug, anti-lung cancer drug and anti-gastric caner drug.

Description

technical field [0001] The invention belongs to the field of biomedicine, and relates to an anticancer pharmaceutical composition containing biflavone from A. spicosa. Background technique [0002] According to statistics from the Ministry of Health in February 2010, the number of cancer deaths worldwide reaches 10 million each year. At present, one-quarter of the global population's death is caused by cancer, and it is predicted that if the current trend continues, one-half of the deaths will be due to cancer by 2050. The incidence of malignant cancer in my country is increasing at a rate of 2.5-5% per year, and it has become the culprit that seriously endangers human life. Among various types of cancer, lung cancer, gastric cancer, and liver cancer have higher incidence rates. [0003] Blood vessels are necessary for the formation and function maintenance of normal tissues and organs, and are closely related to human developmental disorders and various diseases caused by...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P35/00A61K31/352
Inventor 李振山李菲任广伟
Owner TAISHAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products